companydata.dkcompanydata.dk

Rosco Diagnostica ApS: Financial statements 2025

CVR: 27210341

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Rosco Diagnostica ApS (CVR 27210341) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,512,589 and a net result of DKK -649,434 compared with DKK -820,396 the year before. That is an increase of 43.3% compared with the year before. Equity in the 2025 report amounted to DKK 488,626. The solvency ratio was 21%. The company had 3 employees in the financial year.

Gross Profit
DKK 1,512,589
Profit/Loss
DKK -649,434
Equity
DKK 488,626
Total Assets
DKK 2,330,190
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-1.5M-649K489K3
2024-1.1M-820K1.1M2
2023-1.6M-7.6M77K3
2022-3.6M92K7.6M5
2021-3.4M146K7.6M5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Rosco Diagnostica ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Rosco Diagnostica ApS: The 2024 annual report is outJun 17, 2025

Rosco Diagnostica ApS has published its annual report for 2024. Gross profit came to DKK 1,055,212, and the net result was DKK -820,396.

About Rosco Diagnostica ApS

Rosco Diagnostica ApS is a Danish company of the type Anpartsselskab based in Albertslund, founded in 2003. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named ROSCO DIAGNOSTICA A/S and ROSCA DIAGNOSTICA A/S. The management consists of Søren Anker Nielsen. The company is owned by Alpine-Bio ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 1,512,589 and a net result of DKK -649,434 compared with DKK -820,396 the year before. Equity in the 2025 report amounted to DKK 488,626.

Source: annual report 2025, Danish Business Authority